Product Information
OSELTAMIVIR PHOS 45 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.8309 per EA under NDC 64380079801. Its NADAC has been published 363 times since Nov 14, 2018.
Strength
45 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380079801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209421On Market Since
10/5/2018
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has been published 363 times since Nov 14, 2018, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8309 per EA |
|---|---|
| All-time high | $8.1632 (Nov 14, 2018) |
| All-time low | $0.8309 (Jun 17, 2026) |
| 52-week high | $1.1740 |
| 52-week low | $0.8309 |
| Median price | $1.5655 |
| Average price | $2.3956 |
| Largest weekly change | +69.8% (Feb 22, 2023) |
| Weeks tracked | 363 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 45 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.8309 per EA (NDC 64380079801), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has declined 89.8%. It has been tracked across 363 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 45 MG CAPSULE?
Since Nov 14, 2018, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has ranged from a low of $0.8309 (Jun 17, 2026) to a high of $8.1632 (Nov 14, 2018), with a median of $1.5655 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 45 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 45 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 45 MG CAPSULE?
OSELTAMIVIR PHOS 45 MG CAPSULE (NDC 64380079801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification